NICE recommends SGLT-2 inhibitors with metformin at diagnosis, citing major cardiovascular, renal, and mortality benefits.

The global type 2 diabetes market size surpassed USD 40.09 billion in 2025 and is projected to reach approximately USD 79.25 ...

Learn to manage type 2 diabetes while navigating early-stage Alzheimer's with expert advice on symptoms, simplified routines, and home safety strategies.

A new nationwide analysis shows very early childhood Type 2 diabetes (T2D) is still uncommon but linked with where children ...

Researchers from several partner institutions of the German Center for Diabetes Research (DZD) have collaborated with ...

Eli Lilly and Company has reported detailed findings from the ACHIEVE-3 Phase III trial comparing the efficacy and safety of ...

Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...

More than 38 million Americans have diabetes and of them, up to 95% have type 2 diabetes, according to the Centers for Disease Control and Prevention (CDC). While the condition usually develops in ...

Metformin is particularly effective for people with diabetes or prediabetes who have obesity and have difficulty managing their blood sugar through lifestyle changes alone. Metformin is a widely used ...

As of 2021, researchers estimated that about 10.5% of the global adult population has diabetes, with 90% of that number having type 2 diabetes. Both obesity and type 2 diabetes are known risk factors ...

A recent study has found that eating higher levels of red meat is associated with an increased risk of developing type 2 ...

People who have type 2 diabetes have an increased amount of sugar in their blood, also called blood glucose. Increased blood sugar happens when your body’s insulin doesn’t work as well as it should.